National Audit Office 8 June 2018
- This investigation focuses on primary care, where most spending on generic medicines is incurred, and it sets out the facts in relation to NHS spending on generic medicines, and the 2017-18 increase in spending on certain generic medicines. It also describes possible causes of the price increases in the market for generic medicines and how the Department of Health and Social Care and its arm’s-length bodies responded to the price increases. (Kings Fund summary)
